Expression 	Expression 	 NN	O
,  	,  	 ,	O
Clinical  	Clinical  	 NNP	B-NP
Significance 	Significance 	 NNP	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
Receptor  	Receptor  	 NNP	B-NP
Identification  	Identification  	 NNP	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
Newest  	Newest  	 NNP	I-NP
B7  	B7  	 NNP	I-NP
Family  	Family  	 NNP	I-NP
Member  	Member  	 NNP	I-NP
HHLA2  	HHLA2  	 NNP	I-NP
Protein  	Protein  	 NNP	I-NP
HHLA2  	HHLA2  	 NNP	I-NP
( 	( 	 -LRB-	O
B7H7 	B7H7 	 CD	O
/ 	/ 	 CD	O
B7-H5 	B7-H5 	 CD	B-NP
/ 	/ 	 CD	O
B7y 	B7y 	 CD	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
newly  	newly  	 RB	O
identified  	identified  	 VBN	B-NP
B7  	B7  	 CD	I-NP
family  	family  	 NN	I-NP
member  	member  	 NN	I-NP
that  	that  	 WDT	O
regulates  	regulates  	 VBZ	O
human  	human  	 JJ	O
T-cell  	T-cell  	 JJ	B-NP
functions 	functions 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
its  	its  	 PRP$	O
protein  	protein  	 NN	B-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
organs  	organs  	 NNS	O
and  	and  	 CC	O
significance  	significance  	 NN	B-NP
in  	in  	 IN	O
human  	human  	 JJ	O
diseases  	diseases  	 NNS	O
are  	are  	 VBP	O
unknown 	unknown 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
analyze  	analyze  	 VB	O
HHLA2  	HHLA2  	 CD	B-NP
protein  	protein  	 NN	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
normal  	normal  	 JJ	B-NP
human  	human  	 JJ	I-NP
tissues  	tissues  	 NNS	I-NP
and  	and  	 CC	O
cancers 	cancers 	 NNS	O
,  	,  	 ,	O
as  	as  	 RB	O
well  	well  	 RB	O
as  	as  	 IN	O
its  	its  	 PRP$	O
prognostic  	prognostic  	 JJ	B-NP
significance 	significance 	 NN	I-NP
,  	,  	 ,	O
to  	to  	 TO	O
explore  	explore  	 VB	O
mechanisms  	mechanisms  	 NNS	O
regulating  	regulating  	 VBG	B-NP
HHLA2  	HHLA2  	 CD	I-NP
expression 	expression 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
to  	to  	 TO	O
identify  	identify  	 VB	O
candidate  	candidate  	 NN	B-NP
HHLA2  	HHLA2  	 CD	I-NP
receptors 	receptors 	 NNS	I-NP
.  	.  	 .	O
An  	An  	 DT	O
immunohistochemistry  	immunohistochemistry  	 JJ	B-NP
protocol  	protocol  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
flow  	flow  	 NN	B-NP
cytometry  	cytometry  	 NN	I-NP
assay  	assay  	 NN	I-NP
with  	with  	 IN	O
newly  	newly  	 RB	O
generated  	generated  	 VBN	O
monoclonal  	monoclonal  	 JJ	B-NP
antibodies  	antibodies  	 NNS	I-NP
were  	were  	 VBD	O
developed  	developed  	 VBN	O
to  	to  	 TO	O
examine  	examine  	 VB	O
HHLA2  	HHLA2  	 CD	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
HHLA2  	HHLA2  	 NNP	B-NP
gene  	gene  	 NN	I-NP
copy-number  	copy-number  	 JJ	O
variation  	variation  	 NN	O
was  	was  	 VBD	O
analyzed  	analyzed  	 VBN	O
from  	from  	 IN	O
cancer  	cancer  	 NN	B-NP
genomic  	genomic  	 NN	I-NP
data 	data 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
combination  	combination  	 NN	O
of  	of  	 IN	O
bioinformatics  	bioinformatics  	 JJ	B-NP
analysis  	analysis  	 NN	I-NP
and  	and  	 CC	O
immunologic  	immunologic  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
was  	was  	 VBD	O
established  	established  	 VBN	O
to  	to  	 TO	O
explore  	explore  	 VB	O
HHLA2  	HHLA2  	 CD	B-NP
receptors 	receptors 	 NNS	I-NP
.  	.  	 .	O
HHLA2  	HHLA2  	 NNP	B-NP
protein  	protein  	 NN	I-NP
was  	was  	 VBD	O
detected  	detected  	 VBN	O
in  	in  	 IN	O
trophoblastic  	trophoblastic  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
placenta  	placenta  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
epithelium  	epithelium  	 NN	B-NP
of  	of  	 IN	O
gut 	gut 	 NN	O
,  	,  	 ,	O
kidney 	kidney 	 NN	O
,  	,  	 ,	O
gallbladder 	gallbladder 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
breast 	breast 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
in  	in  	 IN	O
most  	most  	 RBS	O
other  	other  	 JJ	O
organs 	organs 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
HHLA2  	HHLA2  	 CD	B-NP
protein  	protein  	 NN	I-NP
was  	was  	 VBD	O
widely  	widely  	 RB	O
expressed  	expressed  	 VBN	O
in  	in  	 IN	O
human  	human  	 JJ	O
cancers  	cancers  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
breast 	breast 	 NN	O
,  	,  	 ,	O
lung 	lung 	 NN	O
,  	,  	 ,	O
thyroid 	thyroid 	 NN	B-NP
,  	,  	 ,	O
melanoma 	melanoma 	 NN	B-NP
,  	,  	 ,	O
pancreas 	pancreas 	 NN	O
,  	,  	 ,	O
ovary 	ovary 	 NN	B-NP
,  	,  	 ,	O
liver 	liver 	 NN	O
,  	,  	 ,	O
bladder 	bladder 	 NN	O
,  	,  	 ,	O
colon 	colon 	 NN	O
,  	,  	 ,	O
prostate 	prostate 	 NN	B-NP
,  	,  	 ,	O
kidney 	kidney 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
esophagus 	esophagus 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
50  	50  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	B-NP
I-III  	I-III  	 JJ	I-NP
triple-negative  	triple-negative  	 JJ	I-NP
breast  	breast  	 NN	I-NP
cancer 	cancer 	 NN	I-NP
,  	,  	 ,	O
56 	56 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
had  	had  	 VBD	O
aberrant  	aberrant  	 JJ	O
expression  	expression  	 NN	O
of  	of  	 IN	O
HHLA2  	HHLA2  	 CD	B-NP
on  	on  	 IN	O
their  	their  	 PRP$	O
tumors 	tumors 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
high  	high  	 JJ	O
HHLA2  	HHLA2  	 CD	B-NP
expression  	expression  	 NN	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
regional  	regional  	 JJ	B-NP
lymph  	lymph  	 JJ	I-NP
node  	node  	 JJ	I-NP
metastasis  	metastasis  	 NN	I-NP
and  	and  	 CC	O
stage 	stage 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
Cancer  	Cancer  	 NNP	B-NP
Genome  	Genome  	 NNP	I-NP
Atlas  	Atlas  	 NNP	I-NP
revealed  	revealed  	 VBD	O
that  	that  	 IN	O
HHLA2  	HHLA2  	 CD	B-NP
copy-number  	copy-number  	 JJ	O
gains  	gains  	 NNS	O
were  	were  	 VBD	O
present  	present  	 JJ	O
in  	in  	 IN	O
29 	29 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
basal  	basal  	 JJ	B-NP
breast  	breast  	 NN	I-NP
cancers 	cancers 	 NNS	I-NP
,  	,  	 ,	O
providing  	providing  	 VBG	O
a  	a  	 DT	O
potential  	potential  	 JJ	B-NP
mechanism  	mechanism  	 NN	I-NP
for  	for  	 IN	O
increased  	increased  	 JJ	O
HHLA2  	HHLA2  	 CD	B-NP
protein  	protein  	 NN	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
breast  	breast  	 JJ	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
Transmembrane  	Transmembrane  	 NNP	B-NP
and  	and  	 CC	I-NP
Immunoglobulin  	Immunoglobulin  	 NNP	I-NP
Domain  	Domain  	 NNP	I-NP
Containing  	Containing  	 NNP	I-NP
2  	2  	 CD	I-NP
( 	( 	 -LRB-	O
TMIGD2 	TMIGD2 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
identified  	identified  	 VBN	O
as  	as  	 IN	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
receptors  	receptors  	 NN	B-NP
for  	for  	 IN	I-NP
HHLA2 	HHLA2 	 CD	I-NP
.  	.  	 .	O
Wide  	Wide  	 JJ	B-NP
expression  	expression  	 NN	I-NP
of  	of  	 IN	I-NP
HHLA2  	HHLA2  	 CD	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
malignancies 	malignancies 	 NN	O
,  	,  	 ,	O
together  	together  	 RB	O
with  	with  	 IN	O
its  	its  	 PRP$	O
association  	association  	 NN	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
prognostic  	prognostic  	 JJ	B-NP
factors  	factors  	 NNS	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
T-cell  	T-cell  	 JJ	B-NP
coinhibitory  	coinhibitory  	 JJ	I-NP
capability 	capability 	 NN	I-NP
,  	,  	 ,	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
the  	the  	 DT	O
HHLA2  	HHLA2  	 JJ	B-NP
pathway  	pathway  	 NN	I-NP
represents  	represents  	 VBZ	O
a  	a  	 DT	O
novel  	novel  	 NN	B-NP
immunosuppressive  	immunosuppressive  	 NN	I-NP
mechanism  	mechanism  	 NN	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
tumor  	tumor  	 NN	B-NP
microenvironment  	microenvironment  	 NNS	I-NP
and  	and  	 CC	O
an  	an  	 DT	O
attractive  	attractive  	 JJ	O
target  	target  	 NN	O
for  	for  	 IN	O
human  	human  	 JJ	O
cancer  	cancer  	 NN	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
